ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Kenneth L. Dorsney, Editor-in-Chief 985 pages (4 pounds!) Buy from Amazon A key component of the commercial and regulatory structure of…
Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
According to the Louisiana Department of Health, an estimated 500 people per year are infected with hepatitis C (HCV) in Louisiana. By 2016, the number of identified HCV cases in that state…
I will be in Philadelphia on April 11th and 12th and would enjoy the opportunity to meet with current and prospective clients to learn more about your needs. If you…
Successful drug patent challengers get 180 days of market protection The Food and Drug Administration rewards successful drug patent challengers by giving them 180 days of generic market exclusivity (see…
Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies
0
This article was originally published by Kiu Tay-Teo, PhD, André Ilbawi, MD, and Suzanne R. Hill, PhD in JAMA Netw Open. 2019;2(1):e186875. under the terms of the CC-BY License. Key Points Question How does income from…
Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration approval of generic drugs and the interaction of patents and FDA law. A practitioner’s guide, it walks the reader…
Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There are fourteen…
Recent successful drug launches indicate a trend toward more specialized, high-priced drugs that treat less-common medical conditions.